Predicting Central Serous Chorioretinopathy Recurrence Using Machine Learning
Source check: Source checked. Not independent scientific confirmation.
Finding: Machine-learning models predict recurrence of central serous chorioretinopathy after laser treatment; the paper reports internal and external test-set accuracy and identifies clinical recurrence predictors. This is retrospective recurrence prediction, not evidence that model-guided care reduces recurrence. Internal and external test cohorts are described and Table 2 reports recurrence performance.
Technology: Supervised ML classifiers predict recurrence from clinical/ophthalmic variables.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Supervised ML classifiers predict recurrence from clinical/ophthalmic variables.
- Test and result
- Machine-learning models predict recurrence of central serous chorioretinopathy after laser treatment; the paper reports internal and external test-set accuracy and identifies clinical recurrence predictors. This is retrospective recurrence prediction, not evidence that model-guided care reduces recurrence.
- Limitation / still unknown
- Internal and external test cohorts are described and Table 2 reports recurrence performance. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.649316/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.